Skip to main content
FinSpry Logo
FinSpry
FATE logo
FATE
(NASDAQ)
Fate Therapeutics, Inc.
$2.52-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Fate Therapeutics (FATE) Stock Price & Financial Analysis

Fate Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.47 - $2.61
52-Week High$3.23
52-Week Low$0.91
Open$2.57
Volume1.63M
Average Volume (3M)4.09M
Market Cap309.68M
Shares Outstanding120.03M
Price to Sales (P/S)51.88
Price to Book (P/B)1.82
EV/EBITDA-3.03
Revenue (TTM)6.32M
Net Income (TTM)-129.91M
Free Cash Flow (TTM)-108.09M
EPS (TTM)$-1.09
Profit Margin-2056.79%
Operating Margin-2207.47%
Return on Equity (ROE)-72.29%
Debt to Equity0.43
50-Day MA$2.35
200-Day MA$1.51
52-Week Change137.39%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Fate Therapeutics

What is the current stock price for FATE?

As of the latest trading session, FATE stock trades at $2.52. The 52-week range is $0.91–$3.23, with a day range of $2.47–$2.61.

What is the P/E ratio for FATE?

The P/E ratio (Price-to-Earnings) for FATE is shown in the Key Statistics section. This valuation metric helps compare Fate Therapeutics, Inc. to industry peers.

Does FATE pay dividends?

Fate Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FATE?

Based on 9 analysts, the consensus for FATE is Buy.

What is the market cap of FATE?

Fate Therapeutics's market capitalization is $302.5M, classifying it as a small-cap company. Fate Therapeutics operates in the Healthcare sector within the Biotechnology industry.